(Q72555958)
Statements
A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma (English)
W F Regine
J Fontanesi
P Kumar
K Zeitzer
C Greenwald
L Bowman
D N Shapiro
B N Rao
1 February 1995